Sagittarius Life Science (3205) — Cash Flow Reinvestment Rate

Latest as of September 2025: 143.42x

Sagittarius Life Science (3205) has a Cash Flow Reinvestment Rate of 143.42x as of September 2025, reinvesting NT$17.93 Million (capex NT$83.00K plus investments NT$17.84 Million) from operating cash flow of NT$125.00K. See Sagittarius Life Science free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

143.42x

(Capex + Investments) / Operating CF

Total Reinvested

NT$17.93 Million

Capex + Investments

Operating Cash Flow

NT$125.00K

TWD

Capital Expenditures

NT$83.00K

TWD

Sagittarius Life Science Cash Flow Reinvestment Rate (2015–2016)

Historical reinvestment intensity for Sagittarius Life Science across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Sagittarius Life Science.

Annual Cash Flow Reinvestment Rate for Sagittarius Life Science (2015–2016)

Year-by-year capital reinvestment analysis for Sagittarius Life Science. See financial agility of Sagittarius Life Science to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (TWD)	Operating CF	Capex	YoY Change
2016	0.29x	NT$104.28 Million	NT$360.37 Million	NT$19.76 Million	▲ +15.2%
2015	0.25x	NT$59.76 Million	NT$237.94 Million	NT$2.95 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow